Lifecore Biomedical, Inc. De (LFCR) FCF Margin (2010 - 2025)

Lifecore Biomedical's FCF Margin history runs 16 years deep, the most recent figure standing at 8.92% for Q2 2025.

• In Q2 2025, FCF Margin fell 693.0% year-over-year to 8.92%; the TTM figure through May 2025 stood at 10.57% (up 357.0% YoY), while the FY2025 annual figure was 10.57%, up 357.0% from the prior year.
• FCF Margin was 8.92% for Q2 2025 at Lifecore Biomedical, up from 12.11% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 15.84% in Q2 2024 to a low of 70.94% in Q1 2023.
• Historically, FCF Margin has averaged 20.46% across 5 years, with a median of 19.07% in 2024.
• The sharpest annual moves came in 2021 and 2024: FCF Margin tumbled 8639 bps in 2021, then soared 4914 bps in 2024.
• A 5-year view of FCF Margin shows it stood at 9.94% in 2021, then plunged by 437 bps to 33.48% in 2022, then jumped by 71 bps to 9.86% in 2023, then plunged by 167 bps to 26.35% in 2024, then surged by 134 bps to 8.92% in 2025.
• The last three FCF Margin figures came in at 8.92% (Q2 2025), 12.11% (Q1 2025), and 26.35% (Q4 2024), per Business Quant data.